Abivax S.A.

Abivax S.A. - PE Ratioverified

AAVXF

Price:

$101.25

Market Cap:

$6.78B

Abivax S.A., a French biopharmaceutical firm, specializes in the discovery and enhancement of pharmaceutical treatments targeting inflammatory conditions, infectious illnesses, and various forms of cancer. The company's flagship compound, ABX464, is currently undergoing Phase IIb clinical evaluations for ulcerative colitis, Crohn's disease, and COVID-19. It is also being assessed in Phase IIa trials for rheumatoid arthritis, and has successfully concluded Phase IIa studies demonstrating viral remission in individuals with HIV. Additionally, Abivax is advancing ABX 196, an investigational immune-enhancing agent, through Phase 1/2 clinical trials for its potential application in treating hepat...[Read more]

Industry

Biotechnology

IPO Date

2016-09-27

Stock Exchange

OTC

Ticker

AAVXF

The PE Ratio as of June 2026 (TTM) for Abivax S.A. (AAVXF) is -18.89

According to Abivax S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -18.89. This represents a change of 442.57% compared to the average of -3.48 of the last 4 quarters.

Abivax S.A. (AAVXF) Historical PE Ratio (quarterly & annually)

How has AAVXF PE Ratio performed in the past?

The mean historical PE Ratio of Abivax S.A. over the last ten years is -8.41. The current -18.89 PE Ratio has changed 22.37% with respect to the historical average. Over the past ten years (40 quarters), AAVXF's PE Ratio was at its highest in in the June 2013 quarter at -0.01. The PE Ratio was at its lowest in in the June 2014 quarter at -65.06.

Quarterly (TTM)
Annual

Average

-8.41

Median

-7.58

Minimum

-24.93

Maximum

-1.94

Abivax S.A. (AAVXF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Abivax S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 932.50%

Maximum Annual PE Ratio = -1.94

Minimum Annual Increase = -81.28%

Minimum Annual PE Ratio = -24.93

Quarterly (TTM)
Annual
YearPE RatioChange
2025-24.93932.50%
2024-2.41-15.67%
2023-2.8647.32%
2022-1.94-81.28%
2021-10.38-20.93%
2020-13.1346.15%
2019-8.9818.37%
2018-7.590.26%
2017-7.5777.84%
2016-4.26-50.36%

Abivax S.A. (AAVXF) Average PE Ratio

How has AAVXF PE Ratio performed in the past?

The current PE Ratio of Abivax S.A. (AAVXF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-10.07

5-year avg

-8.51

10-year avg

-8.41

Abivax S.A. (AAVXF) PE Ratio vs. Peers

How is AAVXF’s PE Ratio compared to its peers?

Abivax S.A.’s PE Ratio is greater than Axsome Therapeutics, Inc. (-67.16), greater than Merus N.V. (-19.52), greater than Rhythm Pharmaceuticals, Inc. (-30.92), greater than Nuvalent, Inc. (-20.37), less than CRISPR Therapeutics AG (-8.70), greater than Arcellx, Inc. (-28.27), less than Cytokinetics, Incorporated (-11.53), less than Jazz Pharmaceuticals plc (547.95), greater than Metsera, Inc. (-23.34), greater than Arrowhead Pharmaceuticals, Inc. (-38.23),

Build a custom stock screener for Abivax S.A. (AAVXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abivax S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Abivax S.A. (AAVXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Abivax S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Abivax S.A.'s PE Ratio?

How is the PE Ratio calculated for Abivax S.A. (AAVXF)?

What is the highest PE Ratio for Abivax S.A. (AAVXF)?

What is the 3-year average PE Ratio for Abivax S.A. (AAVXF)?

What is the 5-year average PE Ratio for Abivax S.A. (AAVXF)?

How does the current PE Ratio for Abivax S.A. (AAVXF) compare to its historical average?